Related content

Peroxisome proliferator-activated receptor γ ligand inhibits cell growth and invasion of human pancreatic cancer cells

By Hashimoto Koji   Ethridge Richard   Evers B.  

International Journal of Gastrointestinal Cancer, Vol. 32, Iss. 1, 2002-08 ,pp. : 7-22

Humana Press, Inc

Access to resources Recommend Favorite

Use of the Peroxisome Proliferator-Activated Receptor (PPAR)  Ligand Troglitazone as Treatment for Refractory Breast Cancer: A Phase II Study

By Burstein H.J.  

Breast Cancer Research and Treatment, Vol. 79, Iss. 3, 2003-06 ,pp. : 391-397

Springer Publishing Company

Access to resources Recommend Favorite

Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers

By Yokoyama Yoshihito   Xin Bing   Shigeto Tatsuhiko   Mizunuma Hideki  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 8, 2011-08 ,pp. : 1219-1228

Springer Publishing Company

Access to resources Recommend Favorite

Growth Inhibition and Differentiation Induced by Peroxisome Proliferator Activated Receptor Gamma Ligand Rosiglitazone in Human Melanoma Cell Line A375

By  

Medical Oncology, Vol. 23, Iss. 3, 2006-09 ,pp. : 393-402

Humana Press, Inc

Access to resources Recommend Favorite

The Role of Peroxisome Proliferator-Activated Receptor-&ggr; in Breast Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 9, 2012-11 ,pp. : 1025-1044

Bentham Science Publishers

Access to resources Recommend Favorite